2019 was an eventful year in the BioHealth Capital Region (BHCR), to say the least, and BioBuzz has been there to document it every step of the way.
Whether it was the retirement of the MedImmune brand, Viela Bio’s $150M IPO, the $1.2B acquisition of Paragon Bioservices, Kite Pharma’s new manufacturing site in Frederick County, Maryland, an HIV cure emerging in Maryland or our continued coverage of the region’s expanding cell and gene therapy cluster-it’s been a truly remarkable year within the BHCR.
Image: https://biobuzz.io
{iframe}https://biobuzz.io/2019s-top-10-most-read-news-stories-from-the-biohealth-capital-region/{/iframe}